Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia.

Guzman ML, Yang N, Sharma KK, Balys M, Corbett CA, Jordan CT, Becker MW, Steidl U, Abdel-Wahab O, Levine RL, Marcucci G, Roboz GJ, Hassane DC. Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia. Mol Cancer Ther 2014;13:1979-1990. Published Online First June 16,…

Read More

Affinity-Based Proteomics Reveal Cancer-Specific Networks Coordinated by Hsp90

Moulick, Ahn, Zong, Rodina, Cerchietti, DaGama, Caldas-Lopes, Beebe, Perna, Hatzi, Vu, Zhao, Zatorska,Taldone, Smith-Jones, Alpaugh, Gross, Pillarsetty, Ku, Lewis, Larson, Levine, Erdjument-Bromage, Guzman, Nimer, Melnick, Neckers, Chiosis. Affinity-Based Proteomics Reveal Cancer-Specific Networks Coordinated by Hsp90. Nat Chem Biol. 2011 Sep 25; 7(11): 818–826. Published online 2011 Sep 25. doi: 10.1038/nchembio.670

Read More